Melanoma Program Leader: Lynn M. Schuchter, MD
Penn's Melanoma/Pigmented Lesion Clinic was founded in the early 1970s by Wallace H. Clark Jr., MD, who for decades was recognized as the premier expert in melanoma research and treatment.
Dr. Clarke was the first to identify the progressive stages from a mole to early melanoma, making it possible to detect melanoma at a stage when it can be cured.
We were one of the first in the country to establish a Pigmented Lesion Group (PLG) to provide information, evaluation, and genetic counseling for those at increased risk for melanoma.
Our PLG set the standard by creating a national model for melanoma screening.
Through this group's work at Penn and the adjacent Wistar Institute, we better understand risk factors for melanoma and risk factors associated with melanoma occurrence and effective treatments.